| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |